The efficacy and safety of aflibercept and conbercept in diabetic macular edema
Siwei Cai, Qianhui Yang, Xiaorong Li, Yan Zhang Tianjin Medical University Eye Hospital, Tianjin Medical University Eye Institute, College of Optometry and Ophthalmology, Tianjin Medical University, Tianjin 300384, People’s Republic of China Abstract: Diabetic macular edema (DME) has shown...
Saved in:
Main Authors: | Cai S (Author), Yang Q (Author), Li X (Author), Zhang Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of aflibercept in the management of diabetic macular edema
by: Chang AA, et al.
Published: (2015) -
Cytokine and Chemokine Profile Changes in Patients After Intravitreal Conbercept Injection for Diabetic Macular Edema
by: Wei Q, et al.
Published: (2019) -
Pharmacoeconomic analysis of ranibizumab and aflibercept for treatment of diabetic macular edema
by: A. E. Cheberda, et al.
Published: (2018) -
Features of aflibercept plus hyperbaric oxygen therapy for diabetic macular edema
by: V. O. Drozdov, et al.
Published: (2022) -
Evaluation of short-term intraocular pressure changes after intravitreal injection of Conbercept in patients with diabetic macular edema
by: Yunyan Hu, et al.
Published: (2022)